Clinical Trials in Miami

Showing 2141-2160 of 11,431 trials

Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter

NCT06359379

This is a randomized, open-label, phase 2 study evaluating the safety and efficacy of oral ropidoxuridine as a radiation-sensitizing agent in patients with newly diagnosed wild-type isocitrate dehydrogenase glioblastoma with an unmethylated O6-methylguanine-DNA methyltransferase promoter, undergoing standard 60 Gy radiotherapy.

Glioblastoma, IDH-wildtype

Shuttle Pharmaceuticals, Inc.30 participantsStarted Sep 2024

Washington D.C., District of Columbia, United States • Miami, Florida, United States • Hackensack, New Jersey, United States +3 more locations

Enrolling By InvitationPhase 2/3< 1 mile

HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP

NCT05883748

This is an open-label, long-term extension study to investigate the safety, tolerability and efficacy of DISC-1459 in participants with EPP.

Erythropoietic Protoporphyria

Disc Medicine, Inc230 participantsStarted Aug 2023

Birmingham, Alabama, United States • San Francisco, California, United States • Miami, Florida, United States +10 more locations

Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter

HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP

Find Trials by Condition in Miami

Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

Study of Aspirin in Patients With Vestibular Schwannoma

A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease

NATIENS: Optimal Management and Mechanisms of SJS/TEN

Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome

A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity

SyncAV Post-Market Trial

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss

HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)

An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

A Study of GSK5764227 in Participants With. Advanced Solid Tumors (EMBOLD PanTumor-101)

A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

Virtual Walking Intervention for Neuropathic Pain in Spinal Cord Injury

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer